Gouty arthritis market forecast to reach $5.06B by 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Gouty Arthritis Market In 2026 And 2030?

The gouty arthritis market size has shown substantial growth in recent years. It is forecast to expand from $3.69 billion in 2025 to $3.96 billion in 2026, at a compound annual growth rate (CAGR) of 7.2%. The historical growth of this market can be attributed to changes in dietary patterns, the availability of NSAIDs, an increase in arthritis diagnoses, the expansion of rheumatology clinics, and developments in pain management drugs.

The gouty arthritis market is projected to experience substantial expansion over the coming years. It is anticipated to reach a valuation of $5.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This projected growth throughout the forecast period is primarily driven by factors such as an aging population, increased awareness of chronic diseases, a focus on preventive arthritis care, enhanced patient adherence, and the adoption of personalized gout treatment strategies. Significant trends expected during this period include a rising prevalence of hyperuricemia, a growing need for sustained disease management, the development of combination drug therapies, wider acceptance of improved diagnostic imaging, and an increase in lifestyle-based disease management approaches.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Which Drivers Are Supporting The Gouty Arthritis Market Growth?

The expanding occurrence of obesity is projected to fuel the growth of the gouty arthritis market in the future. Obesity, a health condition marked by an excessive accumulation of body fat that poses risks to an individual’s well-being, is commonly assessed using the body mass index (BMI). The prevalence of obesity is climbing, driven by higher intake of calorie-dense, processed foods and inactive lifestyles. Obesity contributes to gouty arthritis by boosting uric acid production and hindering its excretion, resulting in uric acid crystal buildup in joints. Furthermore, additional body weight strains joints, worsening the inflammation and discomfort linked to gout. For instance, in May 2025, the Office for Health Improvement and Disparities, a UK-based government body, reported that an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity from 2023 to 2024, an increase from 64.0% between 2022 to 2023. Consequently, the rising incidence of obesity is propelling the expansion of the gouty arthritis market.

How Is Segmentation Applied In The Gouty Arthritis Market Segment Analysis?

The gouty arthritis market covered in this report is segmented –

1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis

2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Other Treatments

3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities

2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)

Which Trends Are Expected To Impact The Gouty Arthritis Market?

Leading companies within the gouty arthritis market are intensifying their efforts to develop innovative products, such as cortrophin gel, with the goal of providing more effective and targeted therapies for managing the condition. Cortrophin gel, also recognized as repository corticotropin injection, is a purified form of the adrenocorticotropic hormone (ACTH). It is utilized in the treatment of various inflammatory and autoimmune conditions, including gouty arthritis. For example, in October 2023, ANI Pharmaceuticals, a US-based pharmaceutical company, secured approval from the Food and Drug Administration for a new 1-mL vial size of Purified Cortrophin Gel. This product is specifically intended for the adjunctive treatment of certain patients experiencing acute gouty arthritis flares. Presently, Cortrophin Gel holds the distinction of being the sole FDA-approved adrenocorticotropic hormone (ACTH) therapy indicated for treating appropriate patients with acute gouty arthritis flares.

Who Are The Companies Participating In The Gouty Arthritis Market Environment?

Major companies operating in the gouty arthritis market are Horizon Therapeutics plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Novartis International AG, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Teijin Pharma Ltd, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, JW Pharmaceutical, Arthrosi Therapeutics Ltd, XORTX Therapeutics Inc, Atom Therapeutics Co Ltd, Olatec Therapeutics LLC, InventisBio Co Ltd, Shanton Pharma, Selecta Biosciences Inc, LG Chem Ltd, Protalix BioTherapeutics Inc

Get The Full Gouty Arthritis Market Report:

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Which Region Represents The Largest Share Of The Gouty Arthritis Market?

North America was the largest region in the gouty arthritis market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gouty Arthritis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Browse Through More Reports Similar to the Global Gouty Arthritis Market 2026, By The Business Research Company

Emollients Market Report 2026

https://www.thebusinessresearchcompany.com/report/emollients-global-market-report

Gout Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Osteoarthritis Market Report 2026

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795